Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia
Recruiting now
Conditions studied: Vulvodynia
In brief
Vulvodynia is a chronic vulvar pain condition that can significantly affect quality of life. Low-intensity focal extracorporeal shock wave therapy has been proposed as a non-invasive therapeutic option, but real-world data remain limited. This retrospective observational study aims to evaluate the effectiveness of a four-session focal shock wave therapy protocol in women with vulvodynia treated in routine clinical practice at a university hospital. Clinical data collected during standard care, as well as questionnaire responses, will be analyzed to assess changes in symptoms and functional outcomes following treatment.
Key facts
- Study ID
- NCT07553715
- Run by
- Nantes University Hospital
- People needed
- 50
- Starts
- 2026-04-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female patients aged 18 years or older
- Clinical diagnosis of vulvodynia
- Received at least one session of low-intensity focal extracorporeal shock wave therapy in routine clinical practice
You may not qualify if…
- Refusal to participate (non-opposition not obtained)
- Inability to understand French language, preventing completion of study questionnaires
Where it is running
- CHU Nantes- Allergy Department — Nantes, Nantes, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.